| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3acf20930acae4990c5805854202c35e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C53-128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C53-00 |
| filingDate |
2005-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-01-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62108da85253f0e60003539f69063602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c262d998d09c2276f20b78e51ee8352 |
| publicationDate |
2009-01-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7482486-B2 |
| titleOfInvention |
Methods for the preparation and formulation of magnesium valproate hydrate |
| abstract |
The present invention relates to methods for preparing magnesium valproate hydrate and administering this compound to a subject in need of treatment with valproate. Pharmaceutical compositions are also provided that are useful therapies for the treatment of neurological, immunological, and viral-mediated disorders in warm-blooded mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015267-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2456433-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011011376-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2456433-A4 |
| priorityDate |
2005-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |